Finally, in GC cells, ATF2 inhibition reduced the growth and metastasis of cells and promoted sorafenib‐induced ferroptosis, while levobupivacaine induced ferroptosis and decreased the proliferation ability of GC cells by regulating the miR‐489‐3p/SLC7A11 axis.[77] These studies suggested that increasing or decreasing ferroptosis activity could be a potential strategy for cancer treatment. The gene discussed is SLC7A11; the disease is cancer.